about
P3432
P3578
Overexpression of PDZK1 within the 1q12-q22 amplicon is likely to be associated with drug-resistance phenotype in multiple myelomaActivated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myelomaThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivityAn integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma.Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysMalignant hematopoietic cell lines: in vitro models for the study of multiple myeloma and plasma cell leukemia.A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell linesParallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.The phenotype of normal, reactive and malignant plasma cells. Identification of "many and multiple myelomas" and of new targets for myeloma therapy.A landscape of pharmacogenomic interactions in cancer.Characterization of MYC translocations in multiple myeloma cell lines.A comprehensive transcriptional portrait of human cancer cell lines.Integrative high-resolution microarray analysis of human myeloma cell lines reveals deregulated miRNA expression associated with allelic imbalances and gene expression profiles.Molecular characterization of human multiple myeloma cell lines by integrative genomics: insights into the biology of the disease.Fluorescence in situ hybridization analysis shows the frequent occurrence of 14q32.3 rearrangements with involvement of immunoglobulin switch regions in myeloma cell lines.Mcl-1 and Bcl-xL are co-regulated by IL-6 in human myeloma cells.Two distinct human myeloma cell lines originating from one patient with myeloma.
P4510
Q24670255-6791C09E-EEAA-403B-88AC-4A68C06509A5Q28646235-EBAAC597-5A4A-4AA7-940E-9DFC594ED16BQ29547693-F5F24466-71D2-43E7-B410-5C53C3E49544Q33359876-F14B5E42-784F-4365-BD14-8B51AC80CBC3Q33882864-19A072B0-9277-48D5-BB2C-37EFFA163B7EQ33998315-351E0AF5-BC99-4430-A5F8-7C2247465385Q34750568-7D3CF4C3-E1BA-4590-89F9-966C2C279EB3Q35609041-E17CC4EF-A566-4A31-99B7-808569F3C66EQ35938169-94317982-E5E1-480C-B924-C1EB1A0D45F7Q36587131-E85DEC34-9897-44DD-B70B-659E0C9DA8A1Q37140236-42279ABE-F23E-48EC-93E1-0C13A05ABE55Q37331601-DD30BE8D-20A9-4FCB-8411-0B68158FB479Q37854720-37620A93-D2A1-4636-B54B-E728A29E9632Q39869539-729B3EBD-D133-4C17-A1E7-A9E283F9280BQ40195859-6A643DFB-1731-4532-9B5C-0B3CE98B9828Q40965727-C25A9426-8064-46F7-BFBB-339A08F983E4Q52826978-DEC82BB2-C849-4CB2-870D-CAECB44E662BQ52833946-8CE3024D-BFF1-48FC-BDD5-70E73AAA1C5C
P4510
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
name
OPM-2
@de
OPM-2
@en
OPM-2
@fr
OPM-2
@ga
OPM-2
@nl
type
label
OPM-2
@de
OPM-2
@en
OPM-2
@fr
OPM-2
@ga
OPM-2
@nl
altLabel
OPM2
@en
prefLabel
OPM-2
@de
OPM-2
@en
OPM-2
@fr
OPM-2
@ga
OPM-2
@nl